Paydirt
NUVB
Ticker

Nuvation Bio Inc.

NUVB · Healthcare · Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on developing product candidates for cancer treatment

Nuvation Bio Inc. (NUVB), in the Healthcare sector, has 13 disclosed filings on Paydirt over the trailing twelve months from 7 corporate insiders: 1 purchase and 12 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Aug 19 and filed Aug 21. The most active filer was Gary Hattersley with 3 filings.

Add to watchlist
Filings, ttm
13
1 buy · 12 sells
Traders, ttm
7
7 insiders
Volume, ttmiDollar value disclosed in the window
$9.5M
estimated for Congress, as filed for insiders
Median delay
2d
execution to disclosure
Last traded
Aug 19
Filed Aug 21
ADViAverage daily dollar volume
$43.2M
market data
Share price · 12M
$6.99 (+113.8%)
$9.54$6.27$3.01Sep 22 2025Mar 11Aug 27

Adjusted for splits and dividends.

Volume by month
$4.2M$2.1M$0Oct 2024Apr 2025Oct 2025Apr 2026Oct 2024 · buys $220KNov 2024 · sells $163KApr 2025 · buys $986KJun 2025 · buys $895KOct 2025 · sells $502KNov 2025 · sells $4.2MDec 2025 · sells $1.2MApr 2026 · sells $1.3MJun 2026 · buys $118KJun 2026 · sells $1.4MAug 2026 · sells $709K
Buys $2.2M Sells $9.5M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed
GH Gary Hattersley CHIEF SCIENTIFIC OFFICER 3 filings DL Dongfang Liu CHIEF MEDICAL OFFICER 3 filings RM Robert Mashal Director 3 filings KW Kerry Wentworth CHIEF REGULATORY OFFICER 3 filings DH David Hung PRESIDENT AND CEO 2 filings DH David C. Hanley CHIEF TECHNICAL OPERATIONS 1 filing SM Stacy Markel CHIEF PEOPLE OFFICER 1 filing PS Philippe Sauvage Chief Financial Officer 1 filing
Recent filings
Gary HattersleySALE CHIEF SCIENTIFIC OFFICER $709K
100,000 sh × $7.09
Exec Aug 19
Filed Aug 21 · 4:49 PM ET Philippe SauvageSALE Chief Financial Officer $286K
47,668 sh × $6.01
Exec Jun 23
Filed Jun 24 · 5:30 PM ET Kerry WentworthSALE CHIEF REGULATORY OFFICER $379K
63,000 sh × $6.02
Exec Jun 23
Filed Jun 24 · 5:30 PM ET Stacy MarkelSALE CHIEF PEOPLE OFFICER $754K
125,000 sh × $6.03
Exec Jun 23
Filed Jun 24 · 5:30 PM ET Robert MashalPURCHASE Director $118K
25,000 sh × $4.73
Exec Jun 9
Filed Jun 11 · 8:02 PM ET Dongfang LiuSALE CHIEF MEDICAL OFFICER $251K
50,000 sh × $5.02
Exec Apr 17
Filed Apr 21 · 5:30 PM ET Kerry WentworthSALE CHIEF REGULATORY OFFICER $184K
36,750 sh × $5.01
Exec Apr 17
Filed Apr 21 · 5:30 PM ET Kerry WentworthSALE CHIEF REGULATORY OFFICER $904K
200,000 sh × $4.52
Exec Apr 6
Filed Apr 8 · 5:30 PM ET Dongfang LiuSALE CHIEF MEDICAL OFFICER $1.2M
150,000 sh × $7.82
Exec Dec 1 2025
Filed Dec 3 2025 · 5:30 PM ET Dongfang LiuSALE CHIEF MEDICAL OFFICER $140K
20,000 sh × $7.00
Exec Nov 20 2025
Filed Nov 24 2025 · 5:30 PM ET Gary HattersleySALE CHIEF SCIENTIFIC OFFICER $2.7M
369,051 sh across 2 lots
Exec Nov 20 2025
Filed Nov 24 2025 · 5:30 PM ET David C. HanleySALE CHIEF TECHNICAL OPERATIONS $1.4M
200,000 sh × $7.14
Exec Nov 19 2025
Filed Nov 21 2025 · 5:30 PM ET Gary HattersleySALE CHIEF SCIENTIFIC OFFICER $502K
100,000 sh × $5.02
Exec Oct 27 2025
Filed Oct 29 2025 · 5:30 PM ET David HungPURCHASE PRESIDENT AND CEO $895K
500,000 sh × $1.79
Exec Jun 16 2025
Filed Jun 18 2025 · 5:30 PM ET David HungPURCHASE PRESIDENT AND CEO $821K
500,000 sh across 2 lots
Exec Apr 4 2025
Filed Apr 8 2025 · 5:30 PM ET Robert MashalPURCHASE Director $165K
98,900 sh × $1.67
Exec Apr 1 2025
Filed Apr 3 2025 · 5:30 PM ET Junyuan Jerry WangSALE CEO, ANHEART THERAPEUTICS LTD. $163K
56,361 sh × $2.89
Exec Nov 11 2024
Filed Nov 13 2024 · 5:30 PM ET Robert MashalPURCHASE Director $220K
99,981 sh × $2.20
Exec Oct 8 2024
Filed Oct 10 2024 · 5:30 PM ET